Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Obalon Therapeutics Inc (OBLN)

Obalon Therapeutics Inc (OBLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Obalon Therapeutics Inc 5421 Avenida Encinas Suite F Carlsbad CA 92008 USA

www.obalon.com P: 844-362-2566

Description:

Obalon Therapeutics, Inc. is a medical device company. It focused on developing and commercializing medical devices to treat obese and overweight. The company's product consists of Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. Obalon Therapeutics, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 30,567
Shares Outstanding, K 10,022
Annual Sales, $ 1,590 K
Annual Net Income, $ -12,330 K
Last Quarter Sales, $ 60 K
Last Quarter Net Income, $ -1,320 K
60-Month Beta -1.23
% of Insider Shareholders 8.10%
% of Institutional Shareholders 18.64%
Float, K 9,210
% Float 91.90%

Growth:

1-Year Return 211.86%
3-Year Return -87.45%
5-Year Return 0.00%
5-Year Revenue Growth -60.64%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/29/21
Earnings Per Share ttm -1.59
EPS Growth vs. Prev Qtr -158.82%
EPS Growth vs. Prev Year 35.29%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 06/16/21

OBLN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -161.38%
Return-on-Assets % -83.58%
Profit Margin % -775.47%
Debt/Equity 0.00
Price/Sales 20.45
Price/Cash Flow N/A
Price/Book 3.03
Book Value/Share 0.60
Interest Coverage -412.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar